RANTES and eotaxin in tuberculosis

doi:10.3969/j.issn.1673-8640.2015.10.020

Abstract

Abstract:

Tuberculosis remains one of the most common infectious diseases to threat human health. China is the 22nd high tuberculosis burden country. Early correct diagnosis and proper treatment are critical to control Mycobacterium tuberculosis infection. The traditional laboratory diagnosis methods of tuberculosis have many shortcomings, and no excellent biomarkers are found and verified,which hampers and attempts to develop new tests. Along with the increasing research of regulated upon activation normal T cell expressed and secreted(RANTES) and eotaxin, more and more studies indicate that RANTES and eotaxin have potential significance in the diagnosis and monitoring of tuberculosis.

Key words: Regulated upon activation normal T cell expressed and secreted, Eotaxin, Tuberculosis

CLC Number:

R446.5

ZHAO Yanfeng, FENG Xiaoyan, ZHANG Heqiu. RANTES and eotaxin in tuberculosis[J]. Laboratory Medicine, 2015, 30(10): 1048-1052.

References 31

[1]	World Health Organization.Global tuberculosis report 2013[R].Geneva:WHO,2013.
[2]	李婷,卢文,刘淑华. 趋化因子CXCR3及其配体与呼吸系统疾病的关系[J]. 疑难病杂志,2012,11(1):70-73.
[3]	徐勤,张以勤. 趋化因子RANTES在动脉粥样硬化疾病中的作用[J]. 中外健康文摘,2011,8(47):444-446.
[4]	段梅. 趋化性因子RANTES作用的研究[J]. 中国医学工程,2011,10(9):171-174.
[5]	随瑞枝. CCL5基因多态性与宁夏地区结核病遗传易感性的关联性研究[D].银川:宁夏医科大学,2011.
[6]	朱可建,ULRICH MROWIETZ,郑敏. IL-8、MCP-1、RANTES及其受体在树突状细胞中的表达与其趋化性[J]. 中华微生物学和免疫学杂志,2000,20(4):344.
[7]	DORNER BG, SCHEFFOLD A, ROLPH MS, et al.MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines[J]. Proc Natl Acad Sci USA,2002,99(9):6181-6186.
[8]	FERREIRA MA.Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies[J]. Mediators Inflamm,2003,12(5):259-267.
[9]	VIELHAUER V, BERNING E, EIS V, et al.CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome[J]. Kidney Int,2004,66(6):2264-2278.
[10]	POKKALI S, DAS SD.Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis[J]. Hum Immunol, 2009, 70(20):110-115.
[11]	SELVARAJ P, HARISHANKAR M, SINGH B, et al.Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis[J]. Cytokine,2012,60(1):212-219.
[12]	VESOSKY B, ROTTINGHAUS E K, STROMBERG P, et al.CCL5 participates in early protection against Mycobacterium tuberculosis[J]. J Leukoc Biol,2010,87(6):1153-1165.
[13]	MÉNDEZ-SAMPERIO P. Expression and regulation of chemokines in mycobacterial infection[J]. J Infect,2008,57(5):374-384.
[14]	詹前美,胡宏波. RANTES基因多态性表达与肺结核的相关性研究进展[J]. 海南医学,2013,24(11):1648-1649.
[15]	韩锐,綦辉,孙琳,等. CCR2、CCL5、CCR5和CCL1基因多态性与中国汉族儿童结核病易感性的关联研究[J]. 标记免疫分析与临床,2014,21(2):171-175.
[16]	CRUMP MP, RAJARATHNAM K, KIM KS, et al.Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation[J]. J Biol Chem,1998,273(35):22471-22479.
[17]	吴雄英. AMCase,eotaxin-3及IL-13在支气管哮喘发病机制中的作用[J]. 国际病理科学与临床杂志,2013,33(6):533-538.
[18]	高贵民,吴健民. 嗜酸性粒细胞活化趋化因子与支气管哮喘的研究进展[J]. 国际免疫学杂志,2006,29(2):93-96.
[19]	ZIMMERMANN N, DAUGHERTY BL, STARK JM, et al.Molecular analysis of CCR-3 events in eosinophilic cells[J]. J Immunol,2000,164(2):1055-1064.
[20]	HALEY KJ, SUNDAY ME, PORRATA Y, et al.Ontogeny of the eotaxins in human lung[J]. Am J Physiol Lung Cell Mol Physiol,2008,294(2):L214-L224.
[21]	DJOBA SIAWA YA JF, BEYERS N, VAN HELDEN P, et al. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis[J]. Clin Exp Immunol,2009,156(1):69-77.
[22]	YU Y, ZHANG Y, HU S, et al.Different patterns of cytokines and chemokines combined with IFN-γ production reflect Mycobacterium tuberculosis infection and disease[J]. PLoS One,2012,7(9):e44944.
[23]	YANG Q, CAI Y, ZHAO W, et al.IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment[J]. Clin Vaccine Immunol,2014,21(12):1635-1644.
[24]	SHARIFABADI AR, HASSANSHAHI G, GHALEBI SR, et al.All eotaxins CCL11, CCL24 and CCL26 are increased but to various extents in pulmonary tuberculosis patients[J]. Clin Lab,2014,60(1):93-97.
[25]	SHIRATORI B, LEANO S, NAKAJIMA C, et al.Elevated OPN, IP-10, and neutrophilia in loop-mediated isothermal amplification confirmed tuberculosis patients[J]. Mediators Inflamm,2014,2014:513263.
[26]	SUYHERLAND JS, GARBA D, FOMBAH AE, et al.Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion[J]. PLoS One,2012,7(1):e30324.
[27]	ALESSANDRI AL, SOUZA AL, OLIVEIRA SC, et al.Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment[J]. Inflamm Res, 2006,55(12):528-533.
[28]	RIOU C, PEREZ PEIXOTO B, ROBERTS L, et al.Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis[J]. PLoS One,2012,7(5):e36886.
[29]	STEYN A J C.Biomarkers for Tuberculosis and HIV/AIDS[P].[December 182014].
[30]	KOLOBOVNIKOVA IUV, URAZOVA OI, NOVITSKII VV,et al.Molecular mechanisms of formation of blood eosinophilia under pulmonary tuberculosis[J]. Vestn Ross Akad Med Nauk,2012(5):58-62.
[31]	RIFFO-VASQUEZ Y, COATES AR, PAGE CP, et al.Mycobacterium tuberculosis chaperonin 60.1 inhibits leukocyte diapedesis in a murine model of allergic lung inflammation[J]. Am J Respir Cell Mol Biol,2012,47(2):245-252.